PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2009 | 69 | 1 |
Tytuł artykułu

CXCL11 and Interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone

Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Chemokines may play a role in the pathogenesis of multiple sclerosis (MS), facilitating the traffi cking of immune cells across the blood-brain barrier. Interferon-inducible T cell alpha chemoattractant (CXCL11) recruits activated Th1 cells to sites of infl ammation. We have estimated the levels of CXCL11 chemokine and IL-18 also known as IFN-gamma inducing factor in sera of 30 relapsingremitting MS patients during relapse, both before and after methylprednisolone (MP) treatment and compared the results with those in control group. The serum CXCL11 and IL-18 concentrations were measured by the ELISA method. The serum levels of CXCL11 were detectable in 23 relapsing-remitting MS patients. The levels were signifi cantly higher in sera of studied patients before (55.4 ± 63.1 pg/ml) and after steroid therapy (40.7 ± 43.2 pg/ml) in comparison with control group (17 ± 18.3 pg/ml, P=0.002). The serum levels of CXCL11 before and after MP treatment did not differ signifi cantly. The levels of IL-18 were detectable in the sera of all studied MS patients. The serum concentration of IL-18 in relapsing-remitting MS patients before MP therapy was 246.6 ± 143.5 pg/ml and was signifi cantly higher than the level of IL-18 in healthy controls (171.06 ± 56.8 pg/ml, P=0.008). IL-18 levels in the sera of MS patients after steroid therapy was 258.76 ± 292.5 pg/ml and was higher than that in the control group (P=0.006) but did not differ signifi cantly from the serum concentration of IL-18 in the same patients before the onset of MP treatment. The results suggest involvement of CXCL11 and IL-18 in immunopathogenesis of MS.
Słowa kluczowe
Wydawca
-
Rocznik
Tom
69
Numer
1
Opis fizyczny
p.89
Twórcy
  • Department of Clinical Neuroimmunology, University of Medical Sciences, Poznan, Poland
  • Department of Clinical Neuroimmunology, University of Medical Sciences, Poznan, Poland
autor
  • Department of Clinical Neuroimmunology, University of Medical Sciences, Poznan, Poland
  • Neuroimmunological Unit, Mossakowski Medical Research Centre, Polish Academy of Sciences, Poznan, Poland
Bibliografia
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-02f8edc7-f17c-4ca5-ae23-c39a37d159d9
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.